The Board approved and took on record the Unaudited Financial Results for the quarter and half year ended September 30, 2026. Pursuant to Regulation 33 of SEBI LODR Regulations, the company submitted:
- Statement showing Unaudited Financial Results for the quarter and half year ended September 30, 2026
- Limited Review Report on Unaudited Financial Results for the quarter and half year ended September 30, 2026
Financial Performance Highlights
Quarter Ended September 30, 2026 (Unaudited):
- Revenue from operations: ₹2,235.45 lakh
- Other Income: ₹19.00 lakh
- Total Revenue: ₹2,254.49 lakh
- Profit Before Tax: ₹143.91 lakh
- Tax Expense: ₹23.00 lakh (Current Tax)
- Profit for the period: ₹120.91 lakh
- Basic EPS: ₹0.60
- Diluted EPS: ₹0.47
Half Year Ended September 30, 2026 (Unaudited):
- Revenue from operations: ₹4,728.02 lakh
- Other Income: ₹35.13 lakh
- Total Revenue: ₹4,763.15 lakh
- Profit Before Tax: ₹291.74 lakh
- Tax Expense: ₹48.00 lakh (Current Tax)
- Profit for the period: ₹243.74 lakh
- Basic EPS: ₹1.22
- Diluted EPS: ₹1.01
Comparative Performance (Half Year):
- Profit Before Tax increased to ₹291.74 lakh (Sept 2026) from ₹58.28 lakh (Sept 2025)
- Profit for the period increased to ₹243.74 lakh (Sept 2026) from ₹49.28 lakh (Sept 2025)
Balance Sheet Position (as at September 30, 2026)
- Total Assets: ₹4,863.31 lakh
- Equity Share Capital: ₹1,999.85 lakh
- Other Equity: ₹1,042.46 lakh
- Net Worth: ₹3,042.31 lakh
- Non-Current Liabilities: ₹501.02 lakh
- Current Liabilities: ₹1,319.98 lakh
Cash Flow Statement (Six months ended September 30, 2026)
- Net cash used in operating activities: ₹(170.48) lakh
- Net cash used in investing activities: ₹(490.84) lakh
- Net cash from financing activities: ₹616.47 lakh
- Net change in cash and cash equivalents: ₹(44.85) lakh
- Cash and bank balances at beginning: ₹45.84 lakh
- Cash and bank balances at end: ₹0.99 lakh
Significant Cash Flow Components
Investing Activities:
- Payment for purchase of property, plant and equipment: ₹498.07 lakh
- Interest received: ₹7.23 lakh
Financing Activities:
- Proceeds/Payment of long term borrowings: ₹(30.59) lakh
- Proceeds from short term borrowings (net): ₹183.75 lakh
- Proceeds from share warrants: ₹506.25 lakh
- Interest and finance charges paid: ₹(42.94) lakh
Additional Information
- The company operates in a single segment: 'Healthcare Pharma Products'
- The financial results have been prepared in accordance with Indian Accounting Standards (IND AS)
- Figures of previous periods have been rearranged/regrouped where necessary
- The financial results are available at www.bseindia.com and www.veerhealthcare.net